1. Ginsenoside Rp1, A Ginsenoside Derivative, Augments Anti-Cancer Effects of Actinomycin D via Downregulation of an AKT-SIRT1 Pathway
   Un-Jung Yun et al, 2020, Cancers CrossRef
2. Phosphocatalytic Kinome Activity Profiling of Apoptotic and Ferroptotic Agents in Multiple Myeloma Cells
   Emilie Logie et al, 2021, International Journal of Molecular Sciences CrossRef
3. Where We Stand With Precision Therapeutics in Myeloma: Prosperity, Promises, and Pipedreams
   Darren Pan et al, 2022, Frontiers in Oncology CrossRef
4. The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells
   Hai-Ling Gao et al, 2023, Frontiers in Pharmacology CrossRef
5. Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma Cells
   Rachel L. Mynott et al, 2021, ACS Pharmacology & Translational Science CrossRef
6. Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma
   Rachel L. Mynott et al, 2021, ACS Pharmacology & Translational Science CrossRef
7. Role of Sphingolipids in Multiple Myeloma Progression, Drug Resistance, and Their Potential as Therapeutic Targets
   Daniela N. Petrusca et al, 2022, Frontiers in Oncology CrossRef
8. SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation
   Xiaoli Qian et al, 2023, Experimental and Therapeutic Medicine CrossRef
9. The pathogenesis and development of targeted drugs in acute T lymphoblastic leukaemia
   Zhaoying Chen et al, 2023, British Journal of Pharmacology CrossRef
10. Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model
    Chulwon Kim et al, 2019, Biomolecules CrossRef
11. VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study
    Silpa Narayanan et al, 2021, Cancers CrossRef
12. Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells
    Wancheng Guo et al, 2021, Cancers CrossRef
13. Cytotoxic Effect of 6-Ethyl-Chenodeoxycholic Acid and Cabazitaxel on PC-3 Cells
    M. H. Zalzala et al, 2023, Drug development & registration CrossRef
14. USP10 suppresses ABCG2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway
    Jianwei Sun et al, 2023, Journal of Bioenergetics and Biomembranes CrossRef
15. The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter
    Silpa Narayanan et al, 2021, International Journal of Molecular Sciences CrossRef
16. Multidrug efflux transporter ABCG2: expression and regulation
    Samiksha Kukal et al, 2021, Cellular and Molecular Life Sciences CrossRef
17. Molecular and immunological mechanisms of clonal evolution in multiple myeloma
    Stefan Forster et al, 2023, Frontiers in Immunology CrossRef
18. Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
    Yongchao Zhang et al, 2020, Cancers CrossRef